Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
08/2010
08/19/2010WO2010092468A1 Composition comprising alginates and d-limonene to treat gerd and dyspepsia
08/19/2010WO2010092467A1 Medicament comprising terpenoid cholinesterase inhibitor for treatment of dismotility disorder
08/19/2010WO2010092436A1 Pharmaceutical combinations of simethicone and otilonium
08/19/2010WO2010091893A1 Peptides used in the treatment and/or care of the skin, mucous membranes and/or scalp and their use in cosmetic or pharmaceutical compositions
08/19/2010WO2010075263A3 Compounds and methods for enhancing erythropoiesis
08/19/2010WO2010026596A3 Compositions comprising polyhydroxyltate fatty alcohol derivatives and the therapeutic uses
08/19/2010WO2009135581A3 Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
08/19/2010US20100212037 Mia-2 protein
08/19/2010US20100210838 Fluoropyrrolidines having dipeptidyl peptidase enzyme inhibitory activity
08/19/2010US20100210727 Hepoxilin analog enantiomers
08/19/2010US20100210716 Process for Preparing an Alpha-Lipoic Acid/Cyclodextrin Complex and Product Prepared
08/19/2010US20100210705 Pyrrole and Isoindole Carboxamide Derivatives as P2X7 Modulators
08/19/2010US20100210696 5-membered heterocyclic compound
08/19/2010US20100210685 Novel Substituted Indoles
08/19/2010US20100210679 Preventive and therapeutic medicament for gastroesophageal reflux disease
08/19/2010US20100210678 Tricyclic androgen receptor modulator compounds and methods
08/19/2010US20100210660 Heterocyclic FXR Binding Compounds
08/19/2010US20100210657 Bicyclic Benzamides of 3-or 4-Substituted 4-(Aminomethyl)-Piperidine Derivatives
08/19/2010US20100210655 NOVEL sEH INHIBITORS AND THEIR USE
08/19/2010US20100210640 Benzamide derivatives, their preparation and uses in medicine thereof
08/19/2010US20100210637 Heteroaryloxy nitrogenous saturated heterocyclic derivative
08/19/2010US20100210636 Benzoxazinone derivative
08/19/2010US20100210633 Carboxamide compounds and their use
08/19/2010US20100210629 1,6-dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same
08/19/2010US20100210628 NOVEL sEH INHIBITORS AND THEIR USE
08/19/2010US20100210625 Novel1,4-diaza-bicyclo[3.2.2]nonyl heteroaryl derivatives useful as nicotinic acetylcholine receptor ligands
08/19/2010US20100210619 6-Amino-Pyrimidine-4-Carboxamide Derivatives and Related Compounds Which Bind to the Sphingosine 1-Phosphate (S1P) Receptor for the Treatment of Multiple Sclerosis
08/19/2010US20100210618 Piperidine/piperazine derivatives
08/19/2010US20100210593 Pyridine- and Pyrimidinecarboxamides as CXCR2 Modulators
08/19/2010US20100210589 Method for improving hepatic function
08/19/2010US20100210585 Use of hyaluronic acid for the preparation of compositions intended for improving in particular the protective function of the skin, the eye and the mucous
08/19/2010US20100210580 Vitamin B12 Nasal Spray and Method of Use
08/19/2010US20100210572 Hydrolysate of crocin
08/19/2010US20100210567 Use of a tuftsin as a therapeutic agent
08/19/2010US20100210561 Use of peptide as a therapeutic agent
08/19/2010US20100210558 Minigastrin as a therapeutic agent
08/19/2010US20100210557 Use of rfrp, alone or in combination with neurokinin-b, as a therapeutic agent
08/19/2010US20100210556 Use of a peptide as a therapeutic agent
08/19/2010US20100210555 Use of a laminin peptide as a therapeutic agent
08/19/2010US20100210554 Therapeutic uses of gastrin- 1 and g- pen-grgdspca
08/19/2010US20100210540 Use of the peptide combination thymosin beta 4 and delta sleep inducing peptide as a therapeutic agent
08/19/2010US20100210538 Therapeutic uses of intermedin 47 and 53 peptides
08/19/2010US20100210537 Use of a defensin peptide as a therapeutic agent
08/19/2010US20100210535 Therapeutic use of neuropeptide ei and acth 7-38 and compositions thereof
08/19/2010US20100210534 Use of a peptide as a therapeutic agent
08/19/2010US20100210533 Use of urocortin and corticotropin-releasing factor as therapeutic agents
08/19/2010US20100210532 Use of neuropeptide sf, alone or in combination with glp-2, as a therapeutic agent
08/19/2010US20100209541 Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders
08/19/2010US20100209529 Pharmacologic-functioning water and usage of the same
08/19/2010US20100209526 Product comprising a combination of milk serum apoproteins and free fatty acids
08/19/2010US20100209520 Oral pharmaceutical preparation for colon-specific delivery
08/19/2010US20100209515 Electricity-generating particulates and the use thereof
08/19/2010US20100209507 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions
08/19/2010US20100209505 Controlled release pharmaceutical formulations of nitazoxanide
08/19/2010US20100209467 Tdf-related compounds and analogs thereof, analogs and bioactive fragments
08/19/2010US20100209461 Purified component of blue-green algae and method of use
08/19/2010US20100209442 Deglycosylated and desialidated long pentraxin ptx3
08/19/2010US20100209434 Antibody formulation
08/19/2010US20100209433 Methods for the diagnosis and for the treatment of critically ill patients with endothelin, endothelin agonists and adrenomedullin antagonists
08/19/2010US20100209408 Remodeling of Tissues and Organs
08/19/2010US20100209391 Novel inhibitors of hepatitis c virus replication
08/19/2010US20100209359 Medicated chewing gum
08/19/2010CA2755935A1 Hetero ring derivative
08/19/2010CA2752033A1 Antibody to cytolethal distending toxin of campylobacter jejuni
08/19/2010CA2752020A1 Antibiotic therapy to reduce the likelihood of developing post-infectious irritable bowel syndrome
08/19/2010CA2751436A1 Peptides used in the treatment and/or care of the skin, mucous membranes and/or scalp and their use in cosmetic or pharmaceutical compositions
08/18/2010EP2218734A2 Glucagon-like peptide-2 analogs
08/18/2010EP2218718A1 Amorphous form of heterocyclic compound, solid dispersion and medicinal preparation each comprising the same, and process for production of the same
08/18/2010EP2218451A1 Use of FTS for treating malignant disorders
08/18/2010EP2218446A1 Method for producing microcapsule using solid fat
08/18/2010EP2217275A2 Pharmaceutical compositon for cleansing of the bowel
08/18/2010EP2217266A2 A method for treating ailments of the oral cavity with a krill enzyme composition
08/18/2010EP2217264A2 Methods for the treatment of radiation or chemotherapy-induced tissue damage
08/18/2010EP2217245A1 The use of (3-amino-2-fluoropropyl) phosphinic acid for treatment of nerd
08/18/2010EP2217202A2 Oral care product and methods of use and manufacture thereof
08/18/2010EP1767633B1 Novel polypeptide useful for diagnosis and treatment of cancer
08/18/2010EP1451174B1 Process for the preparation of compositions having an increased amount of pharmaceutically active salts of rotamers
08/18/2010EP1411910B1 (+)-cycloolivil as antioxidant obtained from stereospermum personatum
08/18/2010EP1392321B1 Method of treating inflammatory disorders of the gastrointestinal tract using topical active corticosteroids
08/18/2010CN1985880B Chinese herbal medicine for treating gastrointestinal diseases and hemophilia
08/18/2010CN1957972B Composition in use for invigorating primordial energy, benefiting pubic region, preparation method and usage
08/18/2010CN1943619B Method for preparing Chinese medicine origanum volatile oil and its soft capsule
08/18/2010CN1837202B Flavonols with blood-fat-lowering effect
08/18/2010CN1732926B Medicine contained soft capsule
08/18/2010CN1717243B Papaya puree and the use of the same
08/18/2010CN1704121B Anti-angiogenic compositions and methods of use
08/18/2010CN101809027A selective inhibitors of neurotensin degrading enzymes
08/18/2010CN101809018A solids forms of ( s) -ethyl 2-amin0-3- (4- (2 -amino- 6- ( (r) -1- (4-chl0r0-2- o-methyl-ih-pyrazol- 1-yl) phenyl) -2, 2, 2-trifluorethoxy) -pyrimidin-4-yl) phenyl) propanoate
08/18/2010CN101809008A Pharmaceutical composition containing optically active compound having thrombopoietin receptor agonist activity and intermediate thereof
08/18/2010CN101808622A Pharmaceutical composition containing esomeprazole
08/18/2010CN101805737A Ribonucleic acid with liver cancer-related gene DLK1as target and application thereof
08/18/2010CN101805736A Ribonucleic acid with liver cancer-related gene DLK1 as target and application thereof
08/18/2010CN101805688A Mulberry health-care wine and preparation method thereof
08/18/2010CN101805687A Radix rehmanniae health care wine and production method thereof
08/18/2010CN101805686A Pine needle health-care wine
08/18/2010CN101805391A Preparation method of sodium tanshinone IIA for injection
08/18/2010CN101805377A Method for preparing D-mannose and mannan oligosaccharide by using banana root bulb dry powder
08/18/2010CN101805349A Furan-azo- [3,2-g] chromene compound and application thereof
08/18/2010CN101805334A Lamivudin stearate and synthesis method and application
08/18/2010CN101804199A Pharmaceutical composition used for alimentary canals and application thereof
1 ... 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 ... 1258